Skip to Main Content

Make a gift that pays you back

CHARITABLE GIFT ANNUITIES

  • Secure, predictable fixed payments for you or a loved one.
  • Income tax savings.
  • Favorable reporting of capital gains.

Minimum gift of $10,000.

You contribute cash or marketable securities in exchange for Yale’s promise to pay you and, if you wish, your spouse or another annuitant a fixed income for life.

If you transfer appreciated securities, the payment of capital gains tax may be spread over your life expectancy.

The annuity rate is based in part on your age at the time you begin receiving payments.

As a donor, you may qualify for an income tax deduction in the year you make your gift. In most cases, you will receive a portion of your annuity payments tax free.

You may choose to delay the start of your annuity payments for some period of time. The longer the deferral period, the higher the rate you will receive.

CHARITABLE REMAINDER TRUSTS

  • Secure income for you or a loved one.
  • Individual management of your gift.
  • Increased capacity to support Yale School of Medicine.

If you are considering a significant gift to YSM, a charitable remainder trust may be the right option.

You irrevocably transfer assets, such as cash, marketable securities, or real estate, to a trustee who separately manages and invests them.

Charitable remainder trusts may provide income, capital gains, and estate tax savings and can be tailored to meet your personal and financial goals.

If Yale serves as trustee, your gift will benefit from expert asset management, with low administrative costs, under the direction of the Yale Investments Office.

For a saver who started out with little, this gift provides income for life

Harold Bornstein, M.D. ’53 celebrates with Megan Rowlands ’16 after her clinical elective in Mexico, which was funded by Dr. Bornstein and his late wife, Maureen.

Becoming a hope-giver, with an unexpected benefit

Jonathan and Françoise Friedlaender receive income from a charitable gift annuity that will eventually fund cancer research.